Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
Posted on: Friday, 23 May 2008, 18:00 CDT
CORONA, Calif., May 23 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the UBS Global Specialty and Generic Pharmaceuticals Conference on Wednesday, May 28, 2008 at 2:30 p.m. London BST (9:30 a.m. EDT).
This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com/. The webcast can also be accessed at the following URL: http://events.webeventservices.com/ubs/2008/05/28/index.asp.
An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc, headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com/.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.com
Watson Pharmaceuticals, Inc.
CONTACT: Patty Eisenhaur of Watson Pharmaceuticals, Inc.,+1-951-493-5611
Web site: http://www.watson.com/
Source: PRNewswire-FirstCall
Related Articles
- BioCryst to Present at the UBS Global Specialty Pharmaceuticals Conference
- Bentley Pharmaceuticals to Present at the UBS Global Specialty Pharmaceuticals Conference on April 25, 2006
- Bradley Pharmaceuticals to Present at the CIBC Biotechnology and Specialty Pharmaceuticals Conference
- Valeant Pharmaceuticals to Present at CIBC World Markets Biotechnology and Specialty Pharmaceuticals Conference
- SGX Pharmaceuticals to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference
- ISTA Pharmaceuticals to Present at the CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference
- Specialty Pharmaceuticals Business Development and Investor Conference to Take Place May 23-24, 2006, New Brunswick, NJ
- Rare Disorder Patients Face Access Restrictions on Expensive Specialty Pharmaceuticals; Speech Warns of Potential Adverse Changes in Patient Standards of Care
- Cephalon, Inc. Announces Agreement With McNeil Consumer & Specialty Pharmaceuticals to Co-Promote ATTENACE(TM) for Attention-Deficit/Hyperactivity Disorder
- Noven to Present at Banc of America Securities Specialty Pharmaceuticals Conference
 |
 |
User Comments (0)
RSS Feeds